You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor infiltrating lymphocytes (TILs)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Solid Tumor Trial (LM103)

Not yet recruiting
  • Solid Tumor
  • LM103
  • (no location specified)
Jul 25, 2023

Solid Tumor Trial in Tianjin (LM103)

Recruiting
  • Solid Tumor
  • LM103
  • Tianjin, China
    Tianjin Beichen Hospital
Jul 4, 2023

Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Pembrolizumab 25 mg/ml
  • Paclitaxel injection
  • (no location specified)
Oct 11, 2023

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

Metastatic Triple-Negative Breast Carcinoma Trial in Barcelona, Madrid, Pamplona (PD1+ TILs (NUMARZU-001) product infusion)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • PD1+ TILs (NUMARZU-001) product infusion
  • Barcelona, Spain
  • +3 more
Jul 8, 2022

Melanoma, Non Small Cell Lung Cancer, Cervical Carcinoma Trial in Tianjin (Autologous tumor infiltrating lymphocytes (TILs))

Recruiting
  • Melanoma
  • +2 more
  • Autologous tumor infiltrating lymphocytes (TILs)
  • Tianjin, China
    Tianjin Beichen Hospital
Aug 1, 2022

Glioblastoma Multiforme, Adult Trial in Shijiazhuang (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Glioblastoma Multiforme, Adult
  • Tumor Infiltrating Lymphocytes (TIL)
  • Shijiazhuang, Hebei, China
    The Second Hospital of HeBei Medical University
Apr 11, 2022

NSCLC Trial (TILs(Tumor Infiltrating Lymphocytes))

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • TILs（Tumor Infiltrating Lymphocytes）
  • (no location specified)
Jun 2, 2021

Tumor Infiltrating Lymphocytes Trial (Autologous tumor-infiltrating lymphocytes)

Not yet recruiting
  • Tumor Infiltrating Lymphocytes
  • Autologous tumor-infiltrating lymphocytes
  • (no location specified)
Nov 28, 2021

Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

Recruiting
  • Bone Sarcoma
  • +15 more
  • Aldesleukin
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Non Small Cell Lung Cancer Trial in Durham (Ipilimumab, Paclitaxel, Cisplatin, Carboplatin)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Durham, North Carolina
    Duke University Medical Center
Feb 24, 2021

Liver Cancer Trial in Wuhan (Autologous Tumor Infiltrating Lymphocytes)

Recruiting
  • Liver Cancer
  • Autologous Tumor Infiltrating Lymphocytes
  • Wuhan, China
    Tongji Hospital
Oct 9, 2023

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

Active, not recruiting
  • Metastatic Melanoma
  • +2 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Advanced Breast Cancer, Advanced Lung Cancer Trial (Tumor-infiltrating lymphocytes, IL-2)

Not yet recruiting
  • Advanced Breast Cancer
  • Advanced Lung Cancer
  • Tumor-infiltrating lymphocytes
  • IL-2
  • (no location specified)
Oct 26, 2023

Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,

Not yet recruiting
  • Metastatic Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Oct 14, 2022

Advanced Melanoma Trial in Basel (Combination of Tumor-infiltrating lymphocyte transfer with ANV419)

Not yet recruiting
  • Advanced Melanoma
  • Combination of Tumor-infiltrating lymphocyte transfer with ANV419
  • Basel, Switzerland
    University Hospital Basel
May 19, 2023

Tumor-Infiltrating Lymphocytes and Programmed Cell Death -

Recruiting
  • Breast Cancer
  • +2 more
  • Observational Study
  • Lucknow, Uttar Pradesh, India
    Sanjay Gandhi Postgraduate Institute of Medical Sciences
Feb 11, 2022

pCR After Neoadjuvant Therapy in Breast Cancer Patients

Recruiting
  • Breast Cancer
  • TIL assessment in pre-existing histopathological specimens
  • Cairo, Egypt
    Faculty of Medicine, Ain Shams University
Jul 25, 2022

Solid Tumor Trial (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide Capsules)

Not yet recruiting
  • Solid Tumor
  • Tumor Infiltrating Lymphocytes
  • +3 more
  • (no location specified)
Dec 11, 2022

Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating

Recruiting
  • Urothelial Carcinoma
  • Non-Invasive Bladder Urothelial Carcinoma
  • Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
  • Tampa, Florida
    Moffitt Cancer Center
Mar 2, 2023

Advanced Ovarian Cancer, Malignant Melanoma Trial in Toronto (drug, procedure, biological)

Completed
  • Advanced Ovarian Cancer
  • Malignant Melanoma
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Aug 12, 2020

Glioma Trial in Suzhou (Tumor Infiltrating Lymphocytes (TIL))

Recruiting
  • Glioma
  • Tumor Infiltrating Lymphocytes (TIL)
  • Suzhou, Jiangsu, China
    The Second Affiliated Hospital of Soochow University
Dec 19, 2022

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023